Noelia Kunzevitzky

Noelia Kunzevitzky, PhD, currently serves as the Chief Operating Officer and Director of Operations at Emmecell, where efforts focus on developing a cell therapy aimed at treating corneal edema since December 2011. In addition, Noelia is a Co-Founder of CellMP, active since August 2018. Noelia's prior experience includes a role as Quality & Regulatory Affairs Manager at Promedon SA from June 2000 to February 2004. Noelia received a PhD from the Bascom Palmer Eye Institute at the University of Miami in 2009 and completed a postdoctoral program in Bioinformatics at the same university in 2011. An undergraduate degree in Biochemistry and Clinical Chemistry was earned from Universidad Nacional de Córdoba in 2002.